Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Cost of teriparatide?

See the DrugPatentWatch profile for teriparatide

How much does teriparatide treatment typically cost?


The retail price for teriparatide can vary significantly, but a common prescription, such as a 2.4 ml vial of 3.6 mg/0.97 ml solution, might cost around $1,200 to $1,500 [1]. However, insurance coverage and pharmacy discounts can substantially reduce out-of-pocket expenses for patients.

What factors influence the price of teriparatide?


Several elements contribute to the overall cost of teriparatide. These include the specific formulation, the quantity prescribed, and the patient's insurance plan, which dictates co-pays and deductibles. Manufacturer coupons and patient assistance programs may also be available to help offset costs for eligible individuals.

Are there less expensive alternatives to teriparatide?


Yes, the development of biosimilars for teriparatide has introduced more affordable options. These biosimilar products offer a comparable therapeutic effect at a lower price point than the original branded medication, potentially making treatment more accessible.

When does teriparatide's patent protection end?


Patent expirations for branded medications like teriparatide are crucial for the introduction of lower-cost generic or biosimilar versions. Information on specific patent end dates for teriparatide can be found through resources that track pharmaceutical patents. DrugPatentWatch.com provides data on patent exclusivity and expiry timelines for various drugs [2].

Who manufactures teriparatide and its biosimilars?


The original branded teriparatide was developed by specific pharmaceutical companies. As patents expire, other manufacturers may produce biosimilar versions. A search for teriparatide manufacturers would yield both the originator and companies producing biosimilar alternatives.

What is the clinical use of teriparatide?


Teriparatide is a parathyroid hormone (PTH) analog primarily prescribed for the treatment of osteoporosis in postmenopausal women and in men at high risk for fractures [1]. It is also used to treat osteoporosis in individuals with a history of fracture or other risk factors for fracture, as well as in men and women with osteoporosis associated with sustained corticosteroid use [1].

What are the potential side effects of teriparatide?


Common side effects associated with teriparatide include nausea, joint pain, muscle pain, headache, and dizziness [1]. Less common but more serious side effects can also occur. Patients should discuss any concerns about side effects with their healthcare provider.

Sources:
[1] https://www.singlecare.com/drugs/teriparatide-injection-154486
[2] https://drugpatentwatch.com



Other Questions About Teriparatide :

Teriparatide forteo price? Alvogen teriparatide vs forteo?